Analyze Diet
Veterinary ophthalmology2026; 29(5); e70249; doi: 10.1111/vop.70249

Equine Fungal Keratitis due to Cladorrhinum bulbillosum.

Abstract: To describe the case details and treatment of an equine fungal keratitis case caused by Cladorrhinum bulbillosum. Methods: A 14-year-old Bashkir Curly gelding with a complicated corneal ulcer of the left eye. Methods: Corneal cytology was performed, and intraoperative samples were collected for polymerase chain reaction and for aerobic and mycologic cultures. Under general anesthesia, an inferior eyelid subpalpebral lavage system (SPL) was placed to facilitate postoperative therapy. Anterior stromal keratectomy was performed followed by cryotherapy of the keratectomy bed. A biological scaffold graft was secured within the defect and temporary tarsorrhaphy performed to protect the surgical site. Postoperatively, the horse received systemic anti-inflammatories and topical medications via SPL: antibacterials (ofloxacin, cefazolin), antifungals (voriconazole, luliconazole), and anticollagenase (serum) as well as atropine. Reevaluations were performed every 2-3 weeks until discontinuation of medications. Results: Following surgical and medical management, the horse showed improvement with resolution of the corneal ulcer over an 8-week treatment period. Next-generation sequencing identified C. bulbillosum as the predominant organism, and fungal culture supported filamentous fungal infection. Conclusions: C. bulbillosum infection caused equine fungal keratitis in this case. The use of topical voriconazole and luliconazole, combined with surgical intervention (keratectomy, cryotherapy, bio scaffold graft), resulted in a good response. The corneal ulcer healed well with minor scarring over 8 weeks following surgical intervention. To the authors' knowledge, this was the second report of equine fungal keratitis caused by C. bulbillosum. This case highlights the utility of next-generation DNA sequencing and multimodal treatment with adjunctive contemporary therapies.
Publication Date: 2026-08-17 PubMed ID: 42608345PubMed Central: PMC13481282DOI: 10.1111/vop.70249Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This research article presents a detailed case study of fungal keratitis in a horse caused by the rare fungus Cladorrhinum bulbillosum, focusing on diagnosis, treatment, and successful recovery using surgical and topical therapies.

Introduction and Case Background

  • A 14-year-old Bashkir Curly gelding horse developed a complicated corneal ulcer in the left eye.
  • Fungal keratitis is an infection of the cornea caused by fungi, which can be difficult to diagnose and treat due to the fungal organism’s nature and corneal sensitivity.
  • The fungus identified was Cladorrhinum bulbillosum, a rarely reported cause of equine fungal eye infections, marking this as the second documented case.

Diagnostic Methods

  • Corneal cytology was performed initially to assess the cells and presence of infection in the corneal ulcer.
  • Intraoperative samples were collected for:
    • Polymerase chain reaction (PCR) to amplify fungal DNA and identify the causative organism.
    • Aerobic cultures to check for bacterial infection.
    • Mycologic cultures to grow and confirm fungal presence.
  • Next-generation DNA sequencing was used, which helped identify C. bulbillosum as the primary fungal pathogen involved.

Treatment Approach

  • Surgical intervention was necessary due to the complicated nature of the corneal ulcer:
    • Anterior stromal keratectomy: surgical removal of the diseased corneal tissue.
    • Cryotherapy was applied to the keratectomy bed to destroy residual infected cells and limit fungal growth.
    • A biological scaffold graft was placed into the corneal defect to support healing.
    • Temporary tarsorrhaphy (partial eyelid closure) was performed to protect the surgical site during recovery.
  • To facilitate medication delivery, an inferior eyelid subpalpebral lavage system (SPL) was placed under general anesthesia, enabling easy administration of topical drugs postoperatively.
  • Medical management included systemic anti-inflammatory drugs and topical therapies delivered via SPL:
    • Antibacterials: ofloxacin and cefazolin to prevent or treat secondary bacterial infections.
    • Antifungals: voriconazole and luliconazole targeted the fungal infection effectively.
    • Anticollagenase agents (serum) to inhibit corneal degradation enzymes.
    • Atropine to dilate the pupil and relieve pain.

Outcome and Significance

  • The combined surgical and medical treatment led to the resolution of the corneal ulcer over approximately 8 weeks.
  • The corneal healing was successful with only minor scarring, which is a positive outcome considering the severity of fungal keratitis.
  • The case emphasizes:
    • The importance of using advanced diagnostic tools like next-generation sequencing to accurately identify rare fungal pathogens.
    • The benefits of multimodal treatment—combining surgery, cryotherapy, grafting, and broad-spectrum topical antifungals and antibacterials—for complex equine fungal keratitis.
    • The effectiveness of contemporary adjunctive therapies enabling better recovery and preservation of vision in horses affected by fungal corneal infections.
  • This study adds valuable clinical knowledge as one of the very few reports linking Cladorrhinum bulbillosum to equine fungal keratitis, guiding veterinarians in similar future cases.

Cite This Article

APA
Hamilton A, Lacy L, Scherrer N. (2026). Equine Fungal Keratitis due to Cladorrhinum bulbillosum. Vet Ophthalmol, 29(5), e70249. https://doi.org/10.1111/vop.70249

Publication

ISSN: 1463-5224
NlmUniqueID: 100887377
Country: England
Language: English
Volume: 29
Issue: 5
Pages: e70249
PII: e70249

Researcher Affiliations

Hamilton, Abigail
  • New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, Pennsylvania, USA.
Lacy, Loretta
  • New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, Pennsylvania, USA.
Scherrer, Nicole
  • New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, Pennsylvania, USA.

MeSH Terms

  • Animals
  • Horses
  • Horse Diseases / microbiology
  • Horse Diseases / drug therapy
  • Horse Diseases / therapy
  • Horse Diseases / surgery
  • Horse Diseases / diagnosis
  • Eye Infections, Fungal / veterinary
  • Eye Infections, Fungal / microbiology
  • Eye Infections, Fungal / drug therapy
  • Eye Infections, Fungal / therapy
  • Eye Infections, Fungal / diagnosis
  • Male
  • Antifungal Agents / therapeutic use
  • Keratitis / veterinary
  • Keratitis / microbiology
  • Keratitis / drug therapy
  • Corneal Ulcer / veterinary
  • Corneal Ulcer / microbiology

Conflict of Interest Statement

The authors have not used AI to generate any part of the manuscript. The authors declare no conflicts of interest.

References

This article includes 30 references
  1. Maggs DJ. Chapter 10—Cornea and Sclera. Slatter's Fundamentals of Veterinary Ophthalmology 4th ed., 175–202, 2008.
  2. Gilger BC. Equine Ophthalmology. 4th ed., 2022.
  3. Lazareva Y, Rayisyan M, Mironova E. Features of the Clinical Picture of Keratitis in Horses With Different Forms of the Course of the Disease. Open Veterinary Journal 12 (2022): 830.
    pmc: PMC9805768pubmed: 36650853
  4. Roberts DM, Gilger BC, Roberts DM, Gilger BC. Current Therapy and Advancements in the Treatment of Equine Fungal Keratitis. Journal of the American Veterinary Medical Association 262 (2024): S65–S73.
    pubmed: 38991540
  5. Utter ML, Davidson E, Wotman K. Clinical Features and Outcomes of Severe Ulcerative Keratitis With Medical and Surgical Management in 41 Horses (2000–2006). Equine Veterinary Education 21 (2010): 321–327.
  6. Galán A, Martín‐Suárez EM, Gallardo JM, Molleda JM. Clinical Findings and Progression of 10 Cases of Equine Ulcerative Keratomycosis (2004–2007). Equine Veterinary Education 21 (2009): 236–242.
  7. Chopin JB, Sigler L, Connole MD, O'Boyle DA, Mackay B, Goldstein L. Keratomycosis in a Percheron Cross Horse Caused by. Journal of Medical and Veterinary Mycology 35 (1997): 53–55.
    pubmed: 9061586
  8. Zapater RC, Scattini F. Mycotic Keratitis by. Sabouraudia 17 (1979): 65–69.
    pubmed: 571627
  9. Eaton JS, Miller PE, Bentley E, Thomasy SM, Murphy CJ. The SPOTS System: An Ocular Scoring System Optimized for Use in Modern Preclinical Drug Development and Toxicology. Journal of Ocular Pharmacology and Therapeutics 33 (2017): 718–734.
    doi: 10.1089/jop.2017.0108pubmed: 29239680google scholar: lookup
  10. Damerum A, Malka S, Lofgren N. Next‐Generation DNA Sequencing Offers Diagnostic Advantages Over Traditional Culture Testing. American Journal of Veterinary Research 84 (2023): ajvr.23.03.0054.
    pubmed: 37290754
  11. Madrid H, Cano J, Gené J, Guarro J. Two New Species of. Mycologia 103 (2011): 795–805.
    pubmed: 21307165
  12. Martin ME, Guidobono JS, Melignani E, Gasoni L, Saparrat MCN, Barrera VA. Comparative Analysis of the Cellulolytic Enzymatic Ability of Strains Belonging to the Genus (Podosporaceae, Sordariales, Ascomycota) and Preliminary Data for INTA‐AR 59. Fungal Biology 129 (2025): 101617.
    pubmed: 40915665
  13. Gajjar DU, Pal AK, Santos JM, Ghodadra BK, Vasavada AR. Severe Pigmented Keratitis Caused by. Indian Journal of Medical Microbiology 29 (2011): 434–437.
    pubmed: 22120812
  14. Natarajan R, Mehta S. Keratitis: Unraveling an Unusual Infection. Current Fungal Infection Reports 14 (2020): 373–377.
  15. Badreldin I, Justesen B, Lyhne N, Fuursted K, Vestergaard AH, Justesen US. Identification of Microorganisms in Patients With Keratitis by Next‐Generation Sequencing. Acta Ophthalmologica 101 (2023): 353–354.
    pubmed: 36354043
  16. Ma L., Jakobiec F. A., and Dryja T. P., “A Review of Next‐Generation Sequencing (NGS): Applications to the Diagnosis of Ocular Infectious Diseases,” Seminars in Ophthalmology 34 (2019): 223–231.
    pubmed: 31170015
  17. Revankar S. G. and Sutton D. A., “Melanized Fungi in Human Disease,” Clinical Microbiology Reviews 23 (2010): 884–928.
    pmc: PMC2952981pubmed: 20930077
  18. Rex J. H., Pfaller M. A., Walsh T. J., et al., “Antifungal Susceptibility Testing: Practical Aspects and Current Challenges,” Clinical Microbiology Reviews 14 (2001): 643–658.
    pmc: PMC88997pubmed: 11585779
  19. W. M. Berkowski, Jr. , Craft W. F., Whitley R. D., Brooks D. E., and Plummer C. E., “Equine Ulcerative Keratitis With Furrow: A Review of the Outcomes of 72 Cases From 1987 to 2015,” Equine Veterinary Journal 51 (2019): 749–755.
    pubmed: 30883892
  20. Verdenius C. Y., Slenter I. J. M., Hermans H., Broens E. M., and Djajadiningrat‐Laanen S. C., “Equine Ulcerative Keratitis in The Netherlands (2012‐2021): Bacterial and Fungal Isolates and Antibiotic Susceptibility,” Equine Veterinary Journal 57 (2025): 38–46.
    pubmed: 38220439
  21. Wada S., Hobo S., Ode H., Niwa H., and Moriyama H., “Equine Keratomycosis in Japan,” Veterinary Ophthalmology 16 (2013): 1–9.
    pubmed: 22372681
  22. Mustikka M. P., Grönthal T. S. C., and Pietilä E. M., “Equine Infectious Keratitis in Finland: Associated Microbial Isolates and Susceptibility Profiles,” Veterinary Ophthalmology 23 (2020): 148–159.
    pmc: PMC7004187pubmed: 31364808
  23. Galera P. D. and Brooks D. E., “Optimal Management of Equine Keratomycosis,” Veterinary Medicine: Research and Reports 3 (2012): 7–17.
    pmc: PMC6065588pubmed: 30155429
  24. Smith H. L., Love K. R., Antezana A., Barr E. M., Gilger B. C., and Oh A., “Treatment of Equine Keratomycosis, Part 1: Selection of Appropriate Therapy Based on Clinical Presentation and Diagnostic Testing Improves Clinical Outcomes,” Journal of the American Veterinary Medical Association 262 (2024): S74–S84.
    pubmed: 39442544
  25. Smith H. L., Love K. R., Antezana A., Barr E. M., Gilger B. C., and Oh A., “Treatment of Equine Keratomycosis, Part 1: Selection of Appropriate Therapy Based on Clinical Presentation and Diagnostic Testing Improves Clinical Outcomes,” Journal of the American Veterinary Medical Association 262 (2024): 1–11.
    pubmed: 39442544
  26. Graham A. E., Carslake H. B., and Malalana F., “Complications Associated With Subpalpebral Lavage Systems in Upper and Lower Equine Eyelids: A Prospective, Randomised Study in 73 Cases (2015‐2024),” Equine Veterinary Journal 58 (2026): 692–698.
    pmc: PMC13041592pubmed: 40567141
  27. Loomes K., de Grauw J., Gozalo‐Marcilla M., Redondo J. I., and Bettschart‐Wolfensberger R., “A Systematic Review of the Prevalence of Post‐Operative Complications After General Anaesthesia in Adult Horses (2000‐2023),” Equine Veterinary Journal 57 (2024): 827–861.
    pubmed: 39449518
  28. Thibault C. J., Wilson D. V., Robertson S. A., Sharma D., and Kinsley M. A., “A Retrospective Study of Fecal Output and Postprocedure Colic in 246 Horses Undergoing Standing Sedation With Detomidine, or General Anesthesia With or Without Detomidine,” Veterinary Anaesthesia and Analgesia 46, no. 4 (2019): 458–465.
    pubmed: 31196750
  29. Chen Y., Yang W., Gao M., Belin M. W., Yu H., and Yu J., “Experimental Study on Cryotherapy for Fungal Corneal Ulcer,” BMC Ophthalmology 15 (2015): 29, 10.1186/s12886-015-0011-5.
    doi: 10.1186/s12886-015-0011-5pmc: PMC4384297pubmed: 25880872google scholar: lookup
  30. Chen Y., Gao M., Duncan J. K., et al., “Excisional Keratectomy Combined With Focal Cryotherapy and Amniotic Membrane Inlay for Recalcitrant Filamentary Fungal Keratitis: A Retrospective Comparative Clinical Data Analysis,” Experimental and Therapeutic Medicine 12, no. 5 (2016): 3014–3020, 10.3892/etm.2016.3699.
    doi: 10.3892/etm.2016.3699pmc: PMC5103736pubmed: 27882109google scholar: lookup

Citations

This article has been cited 0 times.